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INTRODUCTION 
Chronic Renal Failure is a clinical syndrome due to irreversible 
renal dysfunction leading to excretory, metabolic and synthetic failure 
culminating into accumulation of non-protein nitrogenous substances and 
present with various clinical manifestations. 
End stage renal disease is described as a terminal stage of chronic 
renal failure that without replacement therapy would result in death. 
         Despite various etiologies, CRF is the final common pathway of 
irreversible destruction of nephrons ultimately resulting in alteration of 
‘Milieu interior’ that affects every system in the body.  One such system 
in the body is thyroid hormonal system.  Kidney is closely related to 
thyroid in the fact that it is the only other organ that competes with iodide 
clearance28. 
         Patients with CRF have many signs and symptoms suggestive of 
thyroid dysfunction like sallow complexion, edema, dry skin, cold 
intolerance, decreased BMR, asthenia and hyporeflexia.  So in cases of 
CRF, it is difficult to exclude thyroid dysfunction on mere clinical 
background. 
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         Various studies have been conducted on thyroid function in CRF 
patients. Since the beginning, the results were inconsistent. 
Hyperthyroidism, hypothyroidism and euthyroidism all have been 
reported. 
         The relation between thyroid dysfunction and severity of CRF is not 
clear. Several previous studies debit conflicting results both positive and 
negative. 
         Prevalence of hypothyroidism in end stage renal disease (ESRD) 
have been estimated between 0 and 9%.  There is also increased 
prevalence of goiter in patients with ESRD. 
         In view of variability of thyroid function test in patients with CRF 
in previous studies, a prospective clinical and biochemical study on 
thyroid function in CRF patient in Department of Nephrology, 
Government Stanley Medical College Hospital, has been undertaken. 
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AIMS OF THE STUDY 
1. To study the prevalence of thyroid dysfunction in patients 
with chronic renal failure. 
2. To study the correlation between thyroid dysfunction and 
severity of renal diseases. 
3. To differentiate primary thyroid diseases from thyroid 
dysfunction due to chronic renal failure. 
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REVIEW OF LITERATURE 
1. PHYSIOLOGY OF THYROID HORMONES 
Thyroxine (T4) and Triiodothyronine (T3) are the principle 
hormones produced by thyroid gland. 
Initially iodine is absorbed in the gut and converted to iodide and 
transported in the blood.  It is then actively transferred into the thyroid 
cell by “Iodide trapping”.  The trapped iodide is “Oxidized”  to iodine 
and combines with tyrosine to form Mono iodotyrosine (MIT) and 
Diiodotyrosine (DIT).  MIT and DIT are coupled to form T3 whereas two 
DIT coupled to form T4.  Oxidation, Iodination and coupling reactions are 
catalyzed by “Thyroid peroxidase”.  Thyroid hormone thus produced 
are bound with thyroglobulin until secreted.(Pic.1) 
Once secreted in the blood, it is transported in two forms.  One is 
bound form, in which T3 and T4 are bound to plasma proteins namely 
thyroid binding globulin, prealbumin and albumin. T4 is predominantly 
bound to thyroid binding globulin whereas T3 is predominantly bound to 
albumin.  The other form is free T3 and T4.  These free forms are in 
equilibrium with bound form. 
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In the periphery one third of T4 is converted to T3 by 5’ 
Deiodenase and 45% to rT3 by 5 deiodenase. They are further 
metabolized to Diiodothyronines.  Only about 13% of T3 is produced 
from thyroid gland and remaining 87% is formed from T4.  
Control of thyroid hormones 
The thyroid stimulating hormone (TSH) controls the secretion of 
T3 and T4.  It is secreted in pulsatile manner with peak secretion at night.  
It’s secretion is stimulated by thyrotropin releasing hormone (TRH).  
Both TRH and TSH release are under negative feedback of free T3 and 
T4. (Pic.2) 
Hypothyroidism 
Hypothyroidism is a clinical syndrome caused by decreased level 
of thyroid hormones. It can be primary in which there is intrinsic 
disorder of thyroid gland or it may be secondary in which there is 
pituitary or hypothalamic defect.   
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Florid hypothyroidism can be diagnosed clinically.  The symptoms 
of hypothyroidism in descending order of frequency are: 
¾ Tiredness, weakness 
¾ Dry Skin 
¾ Feeling Cold 
¾ Hair Loss 
¾ Difficulty in concentrating and poor memory 
¾ Constipation 
¾ Weight gain with poor appetite 
¾ Dyspnea 
¾ Hoarse voice 
¾ Menorrhagia (Later amenorrhea) 
¾ Paraesthesia 
¾ Impaired hearing 
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The signs of hypothyroidism in descending order of frequency are 
as follows: 
 Dry coarse skin 
 Cool peripheral extremities 
 Puffy face, hands and feet (myxedema) 
 Diffuse alopecia 
 Bradycardia 
 Peripheral edema 
 Delayed tendon reflex relaxation 
 Carpal tunnel syndrome 
 Serous cavity effusions 
In biochemical studies, TSH is the single most important parameter 
for screening hypothyroidism. A normal TSH level rules out primary 
hypothyroidism but not secondary.  To diagnose primary hypothyroidism 
TSH level should be above 20 µIU/ml or at least above 10 µIU/ml if 
clinical features strongly suggest. 
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In the presence of elevated TSH, low T4 especially free T4 is 
necessary to confirm hypothyroidism.  Circulating free T3 is usually 
reduced.  But it may be normal in 25% of hypothyroid patients.  So, T3 
measurements are not reliable indicators of hypothyroidism. 
Hyperthyroidism 
Hyperthyroidism is a clinical syndrome which results from 
exposure of the body tissues to excess circulating levels of free thyroid 
hormones. 
The symptoms of hyperthyroidism in descending order of 
frequency are as follows. 
 Hyper activity, irritability, dysphonia  
 Heat intolerance and sweating  
 Palpitations 
 Fatigue and weakness 
 Weight Loss with increased appetite 
 Diarrhoea 
 Polyuria 
 Oligomenorrhea, loss of libido 
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         The signs of hyperthyroidism in descending order of frequency are 
as follows:- 
 Tachycardia; atrial fibrillation in elderly 
 Tremor 
 Goiter 
 Warm, moist skin 
 Muscle weakness, proximal myopathy 
 Lid retraction or lag 
 Gynaecomastia 
Laboratory investigation shows TSH below normal level.  Free and 
total thyroid hormone levels are increased. 
In 2 to 5% of patients, only T3 is increased, a condition called “T3 
thyrotoxicosis”. Occasionally, total and free T4 will be increased with 
normal T3 level.  This condition is called “T4 thyrotoxicosis”. 
 11
NON THYROIDAL ILLNESS6,9,23,40,48,53 
Alteration in serum thyroid hormone occurs in wide variety of 
illness which predominantly affect the T3 level in whom no intrinsic 
diseases of thyroid gland is detected.  It was variously termed as “Low T3 
syndrome”, “Sick euthyroid syndrome”, “Non thyroid illness 
syndrome” and “Thyroid hormone adaptation syndrome”. 
This syndrome occurs in wide variety of illness as follows. 
i. Acute critical illness and febrile illness such as 
infection, myocardial infarction, etc., 
ii. Injuries such as burns, trauma, etc., 
iii. Surgery 
iv. Fasting 
v. Diabetes Mellitus 
vi. Liver disease 
vii. Renal disease 
viii. Ketogenic diet 
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ix. Drugs such as Glucocorticoids, dopamine, phenytoin 
and Beta Blocker 
x. Malignancy 
xi. Psychiatric illness 
         In non thyroid illness state, initially there is decrease in serum T3 
level, both total and Free T3(FT3) This is associated with increase in 
reverse T3(rT3). 
As illness progresses, there is decrease in serum T4 also, a state 
called “low T3, T4 State”.  Although total T4 level decreases, the free 
T4(FT4) remains normal or slightly reduced.  In spite of this reduced T3 
and T4 level, serum TSH level remains normal or reduced by which it is 
differentiated from primary hypothyroidism.  But many studies have 
shown slight elevation of TSH level in non thyroidal illness in the 
absence of hypothyroidism7,24,29. 
CHRONIC RENAL FAILURE 
Pathophysiology 
         The unique property of kidney is that in the presence of CRF, 
compensatory and adaptive mechanism maintain acceptable health until 
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the GFR is above 10 to 15 ml/min and life sustaining renal excretory and 
homeostatic function continues  until the GFR is less than 5ml/min. 
Intact nephron hypothesis 
         The explanation proposed for these adaptive mechanism is that in 
CRF there is progressive loss of nephrons, so most of the nephrons are 
non functioning .The remaining few functioning nephrons tend to 
hypertrophy and take an increased work load so that overall loss of 
function is minimized.  This indicates that GFR of the individual 
functioning nephrons has increases above normal, a state known as 
hyperfiltration.  This increase in single nephron GFR in functioning 
nephorns produce an increased volume of filtrate and their tubules 
respond appropriately by excreting fluids and solutes in amounts which 
maintain external balance.  This is due to close integration of glomerular 
and tubular functions called “glomerulotubular balance” preserved until 
terminal stages of CRF.  These above stated popular explanation for 
continuing function in remaining nephrons, is the “intact – nephron 
hypothesis”. 
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Trade Off Hypothesis 
         It is described that adaptation arising in CRF may control one 
abnormality, but only in such a way as to produce other changes 
characteristic of uraemic syndrome.  The mechanism involved is 
unknown.  This trade off hypothesis is described in hormones like 
parathormone, vasopressin and ANP, solutes like sodium, potassium, 
phosphate and others. 
Uraemic Syndrome 
         Uraemic syndrome is a consequence of combination of the effects 
of the retention of waste products in all organ system and the failure of 
both endocrine and hemostatic function of kidney.   
The potential toxic substances that accumulate include purine 
metabolites amines indoles, phenols, myoinositl and acid polyols. 
“Middle molecules” are nitrogenous substances of molecular 
weight between 50 and 5000 da.  They are also suspected of contributing 
to uraemia. 
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Electrolyte and metabolic changes  
Hyperkalemia usually develops when GFR falls to less than 20-25 
mL/min because of the decreased ability of the kidneys to excrete 
potassium. It can be observed sooner in patients who ingest a potassium-
rich diet or if serum aldosterone levels are low, such as in type IV renal 
tubular acidosis Hyperkalemia in CKD can be aggravated by an 
extracellular shift of potassium, such as that occurs in the setting of 
acidemia or from lack of insulin. 
Metabolic acidosis often is mixed, non–anion gap and anion gap, 
the latter observed generally with CKD stage 5 but with the anion gap 
generally not higher than 20 mEq/L. In CKD, the kidneys are unable to 
produce enough ammonia in the proximal tubules to excrete the 
endogenous acid into the urine in the form of ammonium. In CKD stage 
5, accumulation of phosphates, sulphates, and other organic anions are 
the cause of the small anion gap.  
Extracellular volume expansion and total-body volume overload 
results from failure of sodium and free water excretion. This generally 
becomes clinically manifest when GFR falls to less than 10-15 mL/min, 
when compensatory mechanisms have become exhausted. Patients 
present with peripheral and, not uncommonly, pulmonary edema and 
hypertension. At a higher GFR, excess sodium and water intake could 
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result in a similar picture if the ingested amounts of sodium and water 
exceed the available potential for compensatory excretion  
Hematological changes 
Normochromic normocytic anemia principally develops from 
decreased renal synthesis of erythropoietin, the hormone responsible for 
bone marrow stimulation for red blood cell (RBC) production. It becomes 
more severe as GFR progressively decreases with the availability of less 
viable renal mass. No reticulocyte response occurs. RBC survival is 
decreased, and tendency of bleeding is increased from the uremia-induced 
platelet dysfunction 
Bone changes 
Secondary hyperparathyroidism develops because of 
hypocalcemia, decreased renal synthesis of 1,25-dihydroxycholecalciferol 
(1,25-dihydroxyvitamin D, or calcitriol), and hyperphosphatemia. 
If serum levels of PTH remain elevated, a high–bone turnover 
lesion, known as osteitis fibrosa, develops. This is one of several bone 
lesions, which as a group are commonly known as renal osteodystrophy. 
These lesions develop in patients with severe CKD and are common in 
those with ESRD. Osteomalacia and adynamic bone disease are the 2 
other lesions observed. The former, observed primarily from aluminum 
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accumulation, is markedly less common than the latter, whose etiology is 
unclear. Adynamic bone disease represents the predominant bone lesion 
in patients on chronic peritoneal dialysis and is increasing in frequency. 
Dialysis-related amyloidosis from beta2-microglobulin accumulation in 
patients who have required chronic dialysis for at least 8-10 years is 
another form of bone disease that manifests with cysts at the ends of long 
bones. 
Other changes 
* Pericarditis - Can complicate with cardiac tamponade, 
possibly resulting in death 
* Encephalopathy - Can progress to coma and death 
* Peripheral neuropathy 
* Restless leg syndrome 
* GI symptoms - Anorexia, nausea, vomiting, diarrhea 
* Skin manifestations - Dry skin, pruritus, ecchymosis 
* Fatigue, increased somnolence, failure to thrive  
* Malnutrition 
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* Erectile dysfunction, decreased libido, amenorrhea  
* Platelet dysfunction with tendency to bleeding 
Chronic renal failure as non thyroidal illness 
Chronic renal failure is one among the condition causing low T3 
syndrome. 
TABLE  - B 
CHANGES IN SERUM THYROID HORMONES AND TSH 
CONCENTRATION IN PATIENTS WITH NON THYROIDAL 
ILLNESS 
 
Conditions Serum 
T3 
Serum  
rT3 
Serum 
T4 
Serum 
Free T4 
Serum 
TSH 
Fasting ↓ ↑ = = ↓ 
Mild illness ↓ ↑ = =, ↑ = 
Critical illness ↓ ↑ ↓ =, ↓ ↓ 
Surgical trauma, burns ↓ ↑ ↓ ↓ =, ↓ 
Chronic renal failure ↓ =  =, ↓  =, ↓ =, ↓ 
Hepatitis =, ↑  =,  ↑ =, ↑ =, ↓ = 
HIV infection = ↓ =  =, ↓ =, ↑ 
Depression =, ↓  =, ↑ =, ↑ =, ↑ =, ↓ 
 
=  No change, ↓ Decreased, ↑ Increased 
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         Chronic renal failure has been divided into five stages based on the 
endogenous Creatinine clearance. A typical patient with chronic 
progressive renal diseases may be considered to pass through all 5 stages. 
Stage - I :  (Decreased renal reserve) 
         Endogenous Creatinine clearance is less than 120 ml/min. but more 
than 50 ml/min. 
Stage - II : (Mild renal insufficiency) 
         Creatinine clearance is 30 – 50 ml/min.  Serum Creatinine range 
from 2-4 mg/dl. Symptoms of mild azotemia, inability to concentrate 
urine, leading to polyuria and hypovolemia may be the presenting 
features. 
Stage - III : (Moderate renal failure) 
         Creatinine clearance is less than 30 ml/min but more than 10 
ml/min. This stage may manifest with anaemia, hypertension 
hyperphosphatemia, pruritis, poor intellectual performance and acidosis. 
Stage - IV : (Severe renal failaure) 
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         Creatinine clearance is less than 10 ml/min and more than 5 ml/min.  
Clinical manifestations similar to Stage III. 
Stage - V : (End stage renal disease) 
         End stage renal disease is reached at glomerular filtration rate 
(GFR) of 5 ml/min clinical manifestations are pulmonary odema, 
pericarditis, hyperkalemia, fits and death. Usually serum creatinine is 
over 8 – 10 mg/dl. 
As with other low T3 syndromes, CRF produces decrease in T3 
when GFR falls below 50%.  There is marked decrease of T3 than T4 as 
the GFR decreases.  In ESRD, on average, diminished T4 is found in 29% 
of the patients and diminished T3 in 55% of the patients. 
CRF as low T3 syndrome differs from other conditions causing 
similar illness, by two unique features40. 
* rT3 is usually low or normal in CRF due to redistribution into 
the extra vascular  compartment. 
* Increased incidence of goiter is present in CRF, probably due 
to decreased clearance of iodine by the kidney. 
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PATHOPHYSIOLOGY OF LOW T3 SYNDROME 
As stated above in CRF there is initial decrease in total T3, later T4 
in spite of normal or low TSH. Various mechanism has been proposed for 
the change in Thyroid profile. 
According to the postulates, CRF affect thyroid economy at all 
levels as follows. 
A. Changes in Hypothalamic – pituitary – thyroid axis 
i. Sensitivity of TSH secretion to low thyroid hormone is 
decreased. 
ii.  Limited TSH reserve40 
iii. Due to changes in thyrotrophs or to decreased TRH 
secretion, as manifested by decrease in nocturnal pulses of 
TSH secretion2,17,53. 
iv. Tissue concentration of the hormone may be appropriate for 
the patient, so the patient is in euthyroid state40. 
v. Serum FT3 and FT4 appears normal by sensitive methods3,5. 
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B. Changes in hormone Transport 
i. Presence of protein and non protein inhibitors preventing the 
binding of thyroxine with thyroxine binding protein.  Non 
protein inhibitor is non esterified unsasturated fatty acid22,53. 
ii. Acquired intrinsic structural alternation in the T4 binding 
site23. 
iii. Decrease in concentration of thyroxine binding globulin40,53. 
C. Changes in metabolism 
i. Decrease in the activity of lodothyronine 5 – Deiodinase 
leading to low T340,53 
ii. Increase in Non-deiodinative pathways of iodothyronine 
degradation leading to increased serum T3 sulphate, 
diiodotyrosine, triiodo thryoacetic acid and 
tetraiodothyroacetic acid40,53. 
As previously stated, there is no increase in rT3 in CRF due to 
redistribution of rT3 into extra vascular compartment40,53. 
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D. Changes in plasma membrane Transport 
         T3 and T4 may enter cells not only by diffusion but also by active 
energy dependent transport across plasma membrane. 
         Accumulation of the following substances prevents uptake and 
subsequent deiodination. 
a. 3 – carboxy 4 – methyl 5 – propyl 2 – Furane (CMPF) 
b. Indoxyl sulphate 
In uraemia the action of thyroid hormones at nuclear level are not 
compromised.  Recent study showed increased receptor expression to 
preserve tissue Euthryroidism52.   
DIAGNOSIS OF PRIMARY THYROID DISEASES IN CRF 
Recent studies have shown the prevalence of hypothyroidism is 
increased in chronic renal failure. And also several clinical features of 
both hypothyroidism and chronic renal failure are similar, so 
differentiating both the conditions on clinical background is less likely.  
Hence, all the CRF patients with symptomatology of hypothyroidism 
should be screened for hypothyroidism. 
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Hypothyroidism should be diagnosed only if the following 
prevails. 
a. Basal TSH level should be elevated more than 20 µIU/ml. 
b. Both total and free T4 are distinctly low in the presence of 
normal TBG35. 
c. Presence of anti thyroid antibodies can provide clue for 
hypothyroidism35. 
d. rT3  is not useful because it is decreased in CRF. 
Primary hyperthyroidism is very rare in CRF.  This condition is 
diagnosed by 
a. Low serum TSH 
b. High serum total and free T4 concentration. 
High serum T4 with low T3 in the presence of CRF should make the 
possibility of T4 thyrotoxicosis.  This is because serum T3 level will be 
suppressed in low T3 syndrome with serum T4 unaffected53. 
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MANAGEMENT 
Several studies have been conducted in patients with the T3 
syndrome in order to correct the thyroid profile by treating with L-
Thyroxine18 and Triiodothyronine5. 
Gregory Brent et al18 conducted study in non thyroidal illness 
patients by treating all the patients with serum total T4 less than 5 µg/dl 
with 1.5 µg/Kg of L-thyroxine for 2 weeks.  Thytroxine level increased 
significantly in treated patients.  Serum T3 levels were also raised.  But 
mortality was increased in treatment group on day 5 – 17. 
Carter et al5studied effects of Triiodothyronine administration in 
patients with chronic renal failure.  Study showed serum T3 level did not 
change over a period of 12 weeks.  But the mean serum T4 and TSH 
levels were affected significantly.  There was no subjective improvement 
in these patients. 
Based on this observation, it has been suggested that low serum T3 
level in patients with severe renal failure is metabolically protective and it 
is interpreted as physiological adaptation to reduce basal metabolic rate 
(BMR) and to conserve energy in an adverse environment.  Hence, this 
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condition has been renamed as “Thyroid hormone adaptation 
syndrome”53. 
         Administration of T4 or T3 causes suppression of TSH and increases 
the catabolism.  So, administration of thyroid hormone is not beneficial.  
Study also showed increased morality with the treatment.  Therefore, 
thyroid hormone should not be given in CRF unless true hypothyroidism 
can be documented. 
PROGNOSIS 
Magnitude of the Thyroid dysfunction that occurs in patients with 
chronic renal failure, in general, reflects the severity of the illness.  The 
prognosis is poor in patients with lower serum T3 and T4 or TSH 
concentration.  Studies have shown that after renal transplant the low T3, 
T4 and TSH return to normal level. 
 27
MATERIALS AND METHODS 
Patients admitted to the Nephrology Ward of Government Stanley 
Medical College Hospital with chronic renal failure who are on 
conservative management. 
Study design  
Single Centre, Non randomized prospective study 
Study period 
Study was conducted between September 2006 and August 2007 
for a period of 12 months. 
Sample size 
In the study period of 12 months among patients admitted in 
Nephrology ward after applying inclusion and exclusion criteria, 50 
patients were included in this study. 
Patients who fulfill the criteria for CRF and who are on 
conservative management.  Thyroid profile is done in all patients who 
fulfilling the criteria. 
Informed consent was obtained from all patients. 
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Criteria for Chronic Renal Failure 
1. Symptoms of uraemia for 3 months or more 
2. Elevated blood urea, serum creatinine and decreased 
creatinine clearance. 
3. Ultra sound evidence of chronic renal failure 
a. Bilateral contracted kidneys – size less than 8 cm in 
male and size less than 7 cm in female 
b. Poor corticomedullary differentiation 
c. Type 2 or 3 renal parenchymal changes 
4. Supportive laboratory evidence of CRF like anemia, low 
specific gravity, changes in serum electrolytes, etc., 
5. Radiological evidence of renal osteodystrophy 
Exclusion criteria 
1. Patients underwent pereitoneal dialysis or hemodialysis 
2.  Nephrogenic range of proteinuria 
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3. Low serum protein especially albumin 
4. Other conditions like 
a. Acute illness 
b. Recent surgery, trauma or burns 
c. Diabetes mellitus  
d. Liver diseases 
e. Drugs altering thyroid profile like amiodarone, 
steroids, dopamine, phenytoin, beta-blocker, estrogen 
pills, iodine-containing drugs. 
Details clinical history and clinical examination is undertaken with 
preference to thyroid and renal diseases.  The following investigations are 
performed. 
* Urine for specific gravity and broad cast 
* Peripheral smear for anemia and burr cells 
* Renal parameters like blood urea, serum Creatinine and 
creatinine clearance (using Cockcroft – Gault formula) 
* Serum calcium and phosphorous 
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* Serum cholesterol for hypothyroidism 
* 24 hours urine protein and serum protein to rule out 
nephrotic syndrome and hypoproteinemia respectively  
* ECG and chest X ray to look for features for hypothyroidism 
and renal failure like pleural effusion, pericardial effusion 
* X ray wrist, forearm and spine for evidence of renal 
osteodystrophy 
* USG abdomen for evidence of chronic renal failure 
* FNAC in patients presenting with thyroid swelling 
         After selecting the patients, fulfilling the above criteria, about 5 ml 
of blood sample is collected in nonheparinised serum bottle and sent for 
thyroid profile. 
         Components of thyroid profile in this study 
* Serum triiodothyronine 
* Serum thyroxine 
* Serum thyroid stimulating hormone 
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 Quantitative determination of T3, T4, TSH is done by Enzyme 
Linked Immunosorbent Assay. 
 The normal values:- 
      Total T3  - 0.6 to 2.1 ng/ml 
 Total T4  - 5 to 13 micro g/dl 
 TSH  - 0.4 to 7 micro IU/ml 
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RESULTS AND OBSERVATIONS 
50 patients with CRF who were on conservative management were 
studied.  Among 50 patients, 10 patients were female and 40 patients 
were male.  The age varied from 12 – 70 years.  Among 50 patients, 10 
patients were 30 years and below, 33 patients were in the age group of 30 
– 60 years and 7 patients above 60 years. 
Observation regarding CRF in this study 
The duration of CRF in this study varied from 3 months to 5 years.  
The Creatinine clearance varied from 6 ml/min to 34 ml/min. 20 patients 
had GFR10 ml/min accounting for 40%, 20 patients GFR 11 – 20 ml/min 
accounting for another 40%, remaining 10 patients accounting for 20% 
had GFR more than 20 ml/min. 
Blood urea varied from 64 to 170 mg/dl and Creatinine varied from 
3 mg to 17.2 mg/dl. 
24 hours urinary protein excretion was less than 1 gm/day in all the 
patients in this study group. 
Serum calcium and phosphorous were normal in all the patients.  
80% of the patients had anaemia with peripheral smear revealing 
normocytic normochromic anaemia in 72% and hypochromic anaemia in 
8% of the patients. 
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TABLE - 1 
SERUM CONCENTRATION OF THYROID HORMONE 
 
Thyroid 
hormones 
Normal 
range 
Study 
range 
Mean
Std. 
Dev. 
Mean 
excluding 
hypothyrodism 
Std. 
Dev 
Serum T3 
ng/ml 
0.6 – 2.1 0.2 to 2 0.673 0.414 0.7122 0.4368 
Serum T4 
µg/dl 
5 – 13 0.5 to 9.5 5.622 2.27 5.99 2.08 
Serum 
TSH 
µIU/ml 
0.4 – 7 0.6 to 27 6.53 6.98 4.75 4.151 
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TABLE - 2 
DISTRIBUTION OF LOW T3 AND T4 AMONG VARIOUS 
LEVELS OF TSH 
 
TSH level µ IU/ml 
No. of Patients with 
Low T3 
No. of Patients with 
Low T4 
< 7 16 (57.14%) 8 (53.33%) 
7.1 – 20 7 (25%) 2 (13.33%) 
> 20 5 (17.85%) 5 (33.33%) 
 
 
 
 
 35
 
 
 
TABLE - 3 
ANALYSIS OF THYROID DYSFUNCTION IN THIS STUDY 
Thyroid dysfunction No. of Patients Percentage 
Low T3 syndrome 23 46% 
Low T4 syndrome 10 20% 
Hypothyroidism 5 10% 
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Burr cells were present in 40% of the cases.  One patient had 
pleural effusion in this study. Two patients in this study showed evidence 
of osteodystrophy. 
         Ultra sound abdomen showed evidence of CRF in all patients 
contracted kidney was present in 90% of the patients.  Remaining patients 
had poor corticomedullary differentiation.   
         Among the 50 patients, low serum T3 level was found in 28 patients 
(56%), 5 patients among the low serum T3 level also had high TSH value 
more than 20 µIU/ml with low T4 level and also symptoms suggestive of 
hypothyroidism. 
         These patients as per the criteria were grouped under “primary 
hypothyroidism”. Remaining 6 patients had slightly elevated TSH 
ranging between 9 and 14 µIU/ml.  In these 6 patients, only 3 patients had 
low T3 level, among which only one patient had few clinical features of 
hypothyroidism. So, these 6 patients didn’t satisfy the criteria for 
hypothyroidism fully.  So all 23 patients were grouped under “Low T3 
syndrome” of “sick Euthyroid syndrome”. 
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Features of hypothyroidism in CRF 
         Symptoms of hypothyroidism like tiredness, somnolence, weight 
gain, cold intolerance, constipation, hoarseness of voice etc., were studied 
in CRF in the study population.  35 patients (70%) had the symptoms 
(Table - 7).  Among the 35 patients, 5 of the hypothyroid patients had the 
symptoms (83.33%), 17 (73.91%) of low T3 syndrome patients had  the 
hypothyroid symptoms in CRF without Thyroid dysfunction, 13 patients 
(59.09%) had the symptoms. 
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TABLE - 4 
ANALYSIS OF SERUM T3 T4 AND TSH EXCLUDING 
HYPOTHYROIDISM 
Thyroid 
dysfunction 
No. of Patients 
with Normal 
values 
% 
No. of Pt 
with low 
values 
% 
No. of pt 
with high 
values 
% 
T3 22 44% 23 46% NIL NIL 
T4 35 70% 10 20% NIL NIL 
TSH 38 76% NIL NIL 7 14% 
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TABLE - 5 
AGE INCIDENCE OF LOW T3 SYNDROME IN THIS STUDY 
 
Age in years No. of Patients Low T3 syndrome Percentage 
< 30 10 3 30% 
31 – 60 33 17 51.50% 
> 60 7 3 42.85% 
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TABLE - 6 
SEX INCIDENCE OF LOW T3 SYNDROME IN THIS STUDY 
 
Sex No. of patients 
Low T3 
Syndrome 
Percentage 
Male 40 (80%) 20 50% 
Female 10 (20%) 3 30% 
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Dry, flaky skin was present in 15 patients of which only 4 patients 
were hypothyroid. 
         Sinus bradycardia was present in 7 patients of which only 2 patients 
were hypothyroid.  Delayed ankle jerk was present in 8 patients of which 
only 2 patients were hypothyroid. 
         Hypothyroidism didn’t show any linear correlation with GFR.  
Increased number of hypothyroid patients of about 4 in number were 
present in GFR 11 – 20 ml/min whereas only 2 patients had 
hypothyroidism in GFR less than 10 ml/min. 
         In our study, diffuse thyroid swelling was present in one patient.  
Both of these patients had low T3 syndrome with normal TSH level. 
FNAC of the thyroid swelling showed features of goiter.  This is 
insignificant in the study.   
         Age comparison of Low T3 syndrome in table-5 shows about 30% 
of CRF patients below 30 years of age have low T3 syndrome.  The 
percentage increases to 51.51% in the age group 31 – 60  years.  This is 
probably due to increased CRF patients in this age group.  In age above 
60 years, 42.85% have low T3 syndrome. 
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         Sex incidence in this study (Table-6) shows 50% of males have low 
T3 syndrome and only 30% of the females have low T4 syndrome. 
Observation of T3 in this study 
         T3 level in this study varied from 0.2 to 2 ng/ml.  The mean value of 
T3 is 0.67 ng/ml (Table-1).  Excluding the patients with primary 
hypothyroidism, the mean value is 0.71 ng/ml.  This value was in low 
normal limit.  Excluding hypothyroidism T3 levels were studied in 
relation to GFR.  It was found that mean value of serum T3 is low (0.538 
ng/ml) only in patients with GFR less than 10 ml/min (Table – 10).  The 
mean value is low normal in patients with GFR more than 10 ml/min.  
According to our study, number of patients with low T3 increase with 
increase in severity of the renal failure (Table-8) in spite of low T3 levels.   
Observations of T4 in the study 
         Serum T4 level in the study varies from 0.5 to 9.5 µg/dl. Mean 
value of serum T4 among 50 patients 5.62 µg/dl Excluding hypothyroid 
patients, the mean value is 5.99 µg/dl.  This value is within low normal 
level of T4.   
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TABLE - 7 
ANALYSIS OF HYPOTHYROID SYMPTOMS IN CRF 
Variants 
No. of patients 
with symptoms 
Percentage 
Low T3 Syndrome (n=23) 17 73.91% 
Hypothyroidism (n=5) 5 100% 
CRF without thyroid 
dysfunction (n=22) 
13 59.09% 
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TABLE - 8 
DISTRIBUTION OF LOW T3 AND T4 SYNDROME IN THIS 
STUDY 
Low T3 Syndrome Low T4 Syndrome Creatinine 
Clearance 
ml/min 
No. of 
Patient 
Percentage 
No. of 
patient 
Percentage 
< 10 13 65% 6 30% 
11 – 20 7 35% 3 15% 
> 20 5 30% 1 10% 
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TABLE - 9 
DISTRIBUTION OF THYROID DYSFUNCTION IN THIS STUDY 
AMONG VARIOUS CREATININE CLEARANCE LEVELS 
 
Creatinine 
Clearance ml/min 
No. of 
Patients 
Low T3 
Syndrome
Hypothyroidism 
< 10 20 (40%) 13 (65%) 3 (15%) 
11 – 20 20 (40%) 7 (35%) 2 (10%) 
> 20 10 (20%) 3 (30%) NIL 
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TABLE - 10 
CORRELATION OF THYROID HORMONES WITH SEVERITY 
OF RENAL FAILURE EXCLUDING HYPOTHYROIDISM 
 
Creatinine 
Clearance 
ml/min 
Mean T3 
µg/dl 
Std. 
Dev 
Mean T4 
µg/dl 
Std. 
Dev. 
Mean 
TSH 
µIU/ml 
Std. 
Dev
< 10 (n=17) 0.538 0.40 5.02 2.10 5.22 4.25
11 – 20 
(n=18) 
0.82 0.43 6.69 2.17 3.77 3.78
> 20 0.8 0.31 6.32 2.04 5.72 5.00
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Excluding 5 hypothyroidism patients who have low T4 values, 9 
(21.33%) other patients had T4 level below normal and low T3 
syndrome. 
         Number of patients with low T4 does not correlate with severity of 
renal disease (Table 8).  The mean value of T4 excluding hypothyroidism 
patients was normal at all the stages of renal failure (Table 9).   
         None of the patients had T4 value above normal level. 
Observation of TSH in the study 
         Values of TSH vary from 0.6 to 27 µIU/ml with mean value in 6.53 
µIU/ml. Excluding hypothyroidism mean value is 4.75 µIU/ml.  This 
shows normal serum level of TSH. 
         Among the 50 patients, TSH was normal in 38 patients (76%) and 
values between 7.1 – 20 µIU/ml in 7 patients (14%).  It was elevated 
more than 20 µIU/ml in 5 patients (10%). 
         According to our study, in patients with low T3 syndrome, the mean 
values of TSH in various stages of renal failure are within normal range.  
But the values of TSH didn’t show any linear correlation with GFR. 
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DISCUSSION 
Thyroid dysfunction in CRF was extensively studied by 
Ramirez37. 
Apart from his study, various studies conducted in this line have 
showed different results. 
In our study, patients only on conservative management were 
studied.  This is because thyroid profile undergoes changes due to dialysis 
independent of that due to chronic renal failure.  Dialysis also changes the 
previous serum status of thyroid hormone in the patients with renal 
failure. Many studies have conducted by comparing CRF patients 
conservative Management and Hemodialysis by Ramirez42 and kayima 
et al29. 
         Many studies conducted in CRF patients showed low T3 values.  
Low T3 had been reported in Ramirez et al37, Hegedus et al21, Beckett 
et al37,21,2 studies, that to in severe renal failure.  Ramirez and spectar et 
al37 study showed linear correlation between the mean serum T3 and T4 
and severity of renal failure. 
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         As with other studies, mean T3 level in our study was reduced 
below normal in GFR less than 10 ml/min.  In higher GFR, it was present 
in low normal and there was no linear correlation between T3 level and 
GRF, which is consistent with Avasthi et al study1. 
         Mean T4 level in our study is within normal limits in all levels of 
GFR, but it is in low normal level and also it does not correlate with the 
severity of renal failure. 
         In our study, not all the patients with CRF have low T3 and T4.  It is 
estimated that only 58% (29 patients) of patients have Thyroid Profile 
abnormality.  Remaining 42% of patients have normal thyroid profile. 
         Among 58% of these patients exclude primary hypothyroid patients 
28% have only low T3 level with normal T4 level.  Remaining 20% have 
both low T3 and T4 level. The percentage of patients having low T3 and T4 
gradually increase, with decrease in GFR.  The patient who will develop 
such change in thyroid profile is not known. 
         Excluding hypothyroidism, mean TSH level in our study is within 
normal limits.  The mean TSH levels are also within normal limits for the 
various ranges of GFR.  But TSH level doesn’t show any linear 
correlation with the severity of renal failure.  This is consistent with the 
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study conducted by Spector and Ramirez et al49,37.  These studies 
demonstrated abnormality in hypophyseal mechanism of TSH release in 
uraemic patients as the as the TSH response to the TRH was blunted. 
         Other studies conducted by Joseph et al and Hardy et al24,19 
revealed low T3 T4 level with high TSH level suggesting maintenance of 
pituitary thyroid axis. 
         In our study, excluding those with hypothyroidism, seven patients 
had mild elevation of TSH with low T3 level.  Among these patients, T4 is 
within normal limits in 4 of the patients.  In the remaining 3 patients T4 is 
below normal.  There were no clinical features suggestive of 
hypothyroidism in these patients.  Investigations like FT4,  FT3 TRH 
response and anti thyroid auto antibodies can be done to diagnose 
hypothyroidism in these patients. 
         Out study is consistent with the results of Ramirez et al37 study 
showing low T3, low T4 and normal or mild elevation of TSH. Yet it is 
unclear that to what extent these changes are responsible for the 
manifestations of Uraemic syndrome.  From the various studies it has 
been suggested that this thyroid profile derangements is a part of body 
adaptation mechanism. 
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Dialysis 
         As stated previously, Hemodialysis and continuous ambulatory 
peritoneal dialysis have shown to affect the thyroid profile independently 
of CRF.  Also drugs like heparin, furosemide used during dialysis will 
affect the thyroid profile. 
         Kayima et al29 and Giordano et al16 have conducted studies 
regarding effect of dialysis on CRF patients with thyroid dysfunction.  
These study showed no significant improvement in thyroid profile after 
repeated hemodialysis. 
         But in the patients who have undergone renal transplant surgery, 
most of the thyroid function parameters returned to normal with TSH 
below normal55. 
Hypothyroidism 
         Previous studies by Quion verde et al36 reported high prevalence of 
hypothyroidism in CRF.  It was estimated to be about 5% in patients with 
terminal renal failure. 
Detail study by Kaptein et al25,26 estimated the prevalence of 
primary hypothyroidism was about 2.5 times much frequent in chronic 
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renal failure and dialysis.  The hypothyroidism in CRF was estimated to 
range between 0 and 9.5% Kaptein study also estimated the presence of 
anti thyroid antibody titer in 6.7% of CRF.   
In our study, the hypothyroidism is present in 10% of the patients 
but doesn’t correlate with the severity of the renal failure.  The symptoms 
of hypothyroidism were distributed equally in both hypothyroid and CRF 
patients in our study.  Signs of hypothyroidism were more common in 
CRF without hypothyroidism than with hypothyroidism. 
So, diagnosis of hypothyroidism in CRF mainly rest on TSH level 
which should be very  high (> 20 MIU/dl) with low serum T4. 
         In this study no patient had clinical or biochemical features of 
hyperthyroidism. 
Goiter 
         Ramirez et al42 reported high prevalence of goiter in CRF patients 
especially those on chronic dialysis.  Incidence were increased in end 
stage renal disease.  The possible explanation is due to accumulation of 
iodides in Thyroid gland due to decreased renal clearance in CRF 
patients.  Apart from goiter, study conducted by Hegedus et al21 showed 
thyroid gland volume was significantly increased in patients with CRF. 
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         In our study, only 1 patient had goiter without any clinical or 
biochemical feature of hypothyroidism.  This patient had low T3 level 
with normal TSH and T4.  The number of patients with goiter in our study 
is statistically insignificant.   
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CONCLUSIONS 
1. Thyroid dysfunction occurs in 58% of the chronic renal failure 
patients. 
2. Incidence of hypothyroidism is increased in patients with chronic 
renal failure. 
3. Both clinical and biochemical parameters are essential to diagnose 
hypothyroidism in patients with CRF. 
4. Excluding patients with hypothyroidism T3 level is low in 46% of 
the patients, T4 level is low in 20% of the patients. 
5. Number of patients with low T3 and T4 syndrome progressively 
increase with severity of renal failure. 
6 Serum level of T3 and T4 has no correlation with the severity of 
renal failure. 
7. Alteration in the values of T3 and T4 occurs as a part of body 
adaptations mechanism to conserve energy. 
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PROFORMA 
 
 
Name:      Age:  Sex:  IP 
No: 
Occupation:     Address: 
Past H/O: 
 HT:  Y/N 
 DM:  Y/N 
 Recent surgery/Trauma:  Y/N 
 Drugs:  Y/N 
 Jaundice: Y/N 
 Other systemic illness: Y/N 
Menstrual and Obstetric History: 
General Exam: 
1. Nourishment: 
2. Pallor: 
3. Hyper pigmentation: 
4. Facial puffiness: 
5. Pedal edema: 
6. Skin texture: 
7. Thyroid swelling: 
Pulse: 
BP: 
Respiratory rate: 
Temperature: 
CVS: 
RS : 
 
Abdomen : 
 
CNS : 
 
Investigations: 
 
1. Urine complete examination:    
2. Blood: 
  Hb:  gm/dl 
  TC: 
  DC:  P    %L    %E   % 
  RBC:  Cells/cumm 
  BT:  mnte 
  CT:  mnte 
  Peripheral smear 
3.  Blood 
  Urea: 
  Creatinine: 
  Na: 
  K: 
  Ca:    
  PO4:     
  Serum Cholesterol 
  Serum protein  Total 
      Albumin 
  Globulin 
4.  ECG    
 
5.  X-rays 
  Chest X-ray 
  X-ray wrist, forearm, vertebral spine 
6.  USG abdomen 
 
7.  24 hrs urine protein 
 
8.  Thyroid profile 
  Serum triiodothyroine 
 
  Serum thyroxin 
  Serum thyroid stimulating hormone 
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 TABLE  -  A 
VARIATIONS IN THYROID HORMONES AND BINDING PROTEIN IN HYPER AND HYPOTHYROIDISM 
 
Condition 
Concentrations of 
Binding Proteins 
Total Plasma 
T4, T3, rT3 
Free Plasma 
T4, T3, rT3 
Plasma TSH Clinical State 
Hyperthyroidism Normal High High Low Hyperthyroid 
Hypothyroidism Normal Low Low High Hypothyroid 
 
  CHRONIC RENAL FAILURE MANIFESTATION 
 
MASTER CHART 
  
Renal parameters Thyroid Profile USG Abdomen Miscelaneous
Sl. No. Name Age yrs Sex I.P.No. Symptoms Duration 
Cholestral 
mg/dl 
Ureamg/dl Creatinine mg/dl 
Creatinine clearance 
ml/min T3 ng/ml T4 µg/dl
TGH 
µIU/ml   
1. Munusamy 54 M 020271 5 months 171 88 4.6 19 0.5 3.2 2.3 BLCK 1 
2. Harikrishnan 47 M 062294 24 months 230 103 10.4 8 0.5 5.3 4.5 BLCK 1 
3. Namasivayam 30 M 020434 4 months 164 130 8.5 9 0.5 3.2 2.3 BLCK 1 
4. Mariyappan 64 M 062483 8 months 280 96 4.6 19 1 7.3 7 BLCK 2 
5. Nagammal 52 F 6314 7 months 171 79 4.4 19 2 7.3 2.1 BLCK 1 
6. Ismail 56 M 062517 5 months 160 150 6.2 12 1 4.9 6.5 BLCK 1 
7. Nagaiay 59 M 010038 9 months 180 107 4.6 16 0.2 7.9 3.6 BLCK NIL 
8. Jeyalakshmi 66 F 009978 10 months 110 120 8.5 8 0.2 0.5 27 BLCK 1 
9. Kumar 47 M 062367 6 months 171 124 8.2 9 0.3 3.2 3.1 BLCK 1 
10. Krishnan 27 M 008903 5 months 198 70 5.4 12 0.2 3 10 BLCK 1 
11. Sumathy 48 F 061957 7 months 162 84 3.5 17 1 8.1 1.1 BLCK 1 
12. Lakshmi 63 F 061871 36 months 181 140 16 6 0.2 4.6 1.5 BLCK 1 
13. Rajendran 45 M 062532 9 months 172 87 2.6 34 1.2 8.2 10.5 BLCK 1 
14. Arokiyada 52 M 062373 7 months 190 170 16.4 6 0.2 4.5 2.8 BLCK 1 
15. Gopal 52 M 013547 5 months 184 163 13.6 7 0.2 1.7 7.6 BLCK 3 
16. Kumar 47 M 014428 7 months 190 136 12 8 0.2 8.5 4.5 BLCK 1 
17. Gopirao 27 M 70656 12 months 192 96 5.4 10 0.7 5.5 0.7 CMDL 1 
Renal parameters Thyroid Profile USG Abdomen Miscelaneous
Sl. No. Name Age yrs Sex I.P.No. Symptoms Duration 
Cholestral 
mg/dl 
Ureamg/dl Creatinine mg/dl 
Creatinine clearance 
ml/min T3 ng/ml T4 µg/dl
TGH 
µIU/ml   
18. Indrani 49 F 013823 8 months 185 64 3.2 16 0.4 5.8 3.5 BLCK 4 
19. Chinnaraja 53 M 062738 12 months 190 82 2.8 31 1.1 7.9 2.3 BLCK 1 
20. Rajeswari 62 F 011469 5 months 160 120 12.8 7 0.4 2.8 25 BLCK 1 
21. Ismal 51 M 062968 9 months 184 77 3.4 17 0.7 6.4 1 CMDL NIL 
22. Amirthammal 55 M 011456 24 months 175 135 11.8 8 1.3 5.5 5.8 BLCK 1 
23. Murugesh 24 M 062571 6 months 160 68 2.4 22 0.9 6.1 0.7 BLCK NIL 
24. Mannavalan 77 M 014987 5 months 180 84 3.4 17 0.9 5.4 4.6 BLCK NIL 
25. Sakthevelu 23 M 61214 7 months 176 82 5.4 10 0.7 6.2 2.1 BLCK 1 
26. Ravichandran 45 M 62075 24 months 270 80 3.2 16 1 5.2 6.5 BLCK NIL 
27. Kollappan 67 M 063130 5 years 220 170 14.7 7 0.2 2.2 13.5 BLCK 3 
28. Rajendran 42 M 063883 7 months 210 72 2.4 22 1.1 5.6 7 BLCK 5 
29. Palanisamy 54 M 016627 5 months 186 82 3.2 16 0.4 8.9 2.1 BLCK 2 
30. Mukandiah 29 M 70720 7 months 150 128 12 7 0.75 6.5 3.7 BLCK 1 
31. Ramalingam 56 M 020715 4 months 184 77 3.4 17 0.7 6.4 1 BLCK NIL 
32. Kumar 47 M 063756 7 months 217 90 5.6 10 0.5 5 4.5 BLCK 1 
33. Rajendran 43 M 063600 7 months 133 68 2.4 22 0.9 6.1 0.7 CMDL NIL 
34. Maraghadam 52 F 062655 5 months 296 104 5 17 0.5 2.5 23 BLCK 1 
35. Asokan 27 M 70598 9 months 168 74 2.6 34 0.7 6.2 2.1 BLCK 2 
36. Chinnathambi 47 M 063245 36 months 203 100 13.5 8 1.4 7.8 12.5 BLCK 1 
Renal parameters Thyroid Profile USG Abdomen Miscelaneous
Sl. No. Name Age yrs Sex I.P.No. Symptoms Duration 
Cholestral 
mg/dl 
Ureamg/dl Creatinine mg/dl 
Creatinine clearance 
ml/min T3 ng/ml T4 µg/dl
TGH 
µIU/ml   
37. Mohan 30 M 062650 36 months 184 170 14.7 7 0.2 2.2 23 BLCK 1 
38. Ambigai Raj 68 M 063279 24 months 164 148 8.4 8 0.2 7.4 2 BLCK 1 
39. Premraj 54 M 015799 7 months 186 82 4.6 19 0.4 8.9 2.1 CMDL 2 
40. Nallamuthu 53 M 016546 4 months 133 123 7.6 10 0.4 2.2 5 CMDL 1 
41. Kumar 44 M 063086 9 months 146 98 5.1 12 0.8 6.3 1.7 BLCK NIL 
42. Sankar 48 M 017109 7 months 168 70 2.3 34 0.5 2.2 5 BLCK 1 
43. Noormohamed 30 M 063376 5 months 174 122 5.4 11 0.3 3.2 24.5 BLCK 1 
44. Kuppammal 43 F 014249 7 months 273 92 5.1 12 1 8.8 0.6 BLCK 1 
45. Indrani  48 F 63152 4 months 164 76 3.2 16 0.5 7.2 5.1 BLCK 1 
46. Yakob 64 M 016533 8 months 196 78 4.8 15 0.8 9.5 7 BLCK 2 
47. Murugesh 26 M 063122 7 months 156 82 2.3 34 0.4 5.5 13.5 BLCK 2 
48. Pandian 42 M 063843 5 months 162 78 4.6 34 0.7 9.2 2.7 BLCK 1 
49. C. Mani 56 M 064114 12 months 171 124 6.3 10 0.5 6.2 12.7 BLCK 1 
50. Nallamuthu 52 M 019178 10 months 181 73 2.4 21 1.9 6.9 2.9 BLCK 1 
 
1 - Hypothyroid symptom Present    BLCK - Bilateral Contracted Kidney 
2 - Delayed Ankle Jerk      CMDL - Cortico Medullary Differentiation Lost 
3 - Papilledema 
4 - Goiter 
5 - Pleural Effusion Present 
 
